PURA - Puration Announces Patented Cannabis Extraction Spinoff And Dividend Plan To Optimize Shareholder Value
January 04 2018 - 09:03AM
InvestorsHub NewsWire
Dallas, TX -- January 4, 2018 -- InvestorsHub NewsWire
-- Puration, Inc. (USOTC:
PURA) today announced a spinoff and dividend strategy to
optimize shareholder value. Puration is the sole licensee to
U.S. Patent No. 9,199,960, entitled "METHOD AND APPARATUS FOR
PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS
PLANT." The license permits Puration to produce cannabis
extracts for infusion into recreational, fitness wellness,
alternative medicine and beauty products. Management found
the ideal first application of the extraction technology in the
introduction of its own cannabis infused beverage. Last
year, the company launched EVERx
CBD Infused Sports Water which has since become a
leading brand name in the CBD infused marketplace and one of the
only CBD infused products in the sports nutrition
marketplace. Puration recently announced plans to launch new
cannabis infused beverage lines into Canada’s legal $8 billion
market in addition to announcing plans to open a cannabis
extraction facility into California’s legal $10 billion
market. Puration’s extraction capacity is being structured
into a new subsidiary in a first step to unlock shareholder
value by delineating between the company’s patented
extraction business and cannabis infused beverage business.
The next step will be to spinoff the cannabis extraction subsidiary
in conjunction with a Regulation Crowdfunding transaction to
capitalize the new independently listed company. The spinoff
plan includes a dividend distribution of stock in the new
independently listed company to shareholders of Puration.
Management expects the combination of two stocks, one representing
the value of the cannabis infused beverage operation that remains
in the parent company, and the other representing the value of
patented extraction operation going into the spinoff, will together
yield a greater return for shareholders than a single stock
representing the integrated value of the two. Look for more updates
on the spinoff and dividend plan coming soon.
For more information on Puration visit www.aciconglomerated.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within
the meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any disease.
For More Information Contact:
Brian Shibley,
info@aciconglomerated.com
1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2023 to Mar 2024